South Broward Research

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes3 trials
• Obesity2 trials

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials

Lead sponsor

• Eli Lilly and Company2 trials
• Housey Healthcare ULC1 trial
• Pfizer1 trial

Running trials

• Recruiting

  A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  NCT07595549· Phase 3· Pfizer· Source

• Active, not recruiting

  Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

  NCT06260722· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  NCT05869903· Phase 3· Eli Lilly and Company· Source

• Recruiting

  HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  NCT07546929· Phase 2· Housey Healthcare ULC· Source

  Contact: Kenneth Blaze, DO (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes2 recruiting
• Obesity1 recruiting